EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Re-Analyzing Differentiated High-Grade Thyroid Carcinoma and Elevated Ki-67 Proliferation: A Single-Center Retrospective Study

Gülsüm Karaahmetli iD, Şefika Burçak Polat, Sevgül Fakı iD, Leyla Akdoğan, Feride Pınar Altay iD, Birgül Genç, Ayşegül Aksoy Altınboğa, Oya Topaloğlu, Reyhan Ersoy iD, Bekir Çakır

Journal of Clinical Medicine · 28.05.2026 · 15 (11) · 4173

DOI: 10.3390/jcm15114173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.05.2026. Verfasst von Gülsüm Karaahmetli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Ankara Bilkent City Hospital, Ankara 06800, Türkiye. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The 2022 WHO classification introduced differentiated high-grade thyroid carcinoma (DHGTC) as a distinct category characterized by high-grade features despite maintained differentiation. Therefore, this study aims to evaluate its clinical characteristics, treatment responses, and the prognostic impact of the Ki-67 proliferation index in this patient population.

Methods

We retrospectively reviewed 3100 patients with differentiated thyroid carcinoma (DTC) between 2017 and 2024. From this baseline pool, a total of 56 patients (1.8%) were identified and re-classified as DHGTC based on mitotic count (≥5/2 mm2) and/or tumor necrosis. Additionally, 69 DTC patients (2.2%) with an elevated Ki-67 index (>5%) identified from the same baseline pool—representing an overlapping group with the DHGTC cohort—were analyzed to evaluate its clinical significance.

Results

In the DHGTC group, tumor necrosis was present in 87.5% and high mitotic activity in 19.6% of cases. While all DHGTC patients were classified as high-risk under 2025 American Thyroid Association (ATA) guidelines, 42.8% showed biochemical or structural incomplete response at the last follow-up and 28.6% required additional salvage interventions. In the broader DTC cohort, Ki-67 ≥ 15% was significantly associated with older age, larger tumor size, extensive invasion, and poorer treatment response (p < 0.05). However, within the DHGTC subset, Ki-67 ≥ 15% was only significantly associated with increased lymphovascular invasion and more extensive surgery.

Conclusions

DHGTC carries a significant burden of aggressive histopathological features and a high risk of structural disease persistence or recurrence. While an elevated Ki-67 index (≥15%) serves as an adverse marker in general DTC, its additional prognostic value within the high-grade DHGTC cohort remains inconclusive, potentially obscured by limited statistical power due to small subgroup sizes.

Schlagwörter

Stichwörter der Autor:innen

Ki-67 proliferation indexdifferentiated high-grade thyroid carcinomamitosisnecrosispapillary thyroid carcinomaprognosis

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Ankara Bilkent City Hospital, Ankara 06800, Türkiye.
  • Department of Endocrinology and Metabolism, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06010, Türkiye.
  • Department of Endocrinology and Metabolism, Kirikkale High Specialization Hospital, Kirikkale 71450, Türkiye.
  • Department of Endocrinology and Metabolism, Health Sciences Institute, Ankara Yıldırım Beyazıt University, Ankara 06800, Türkiye.
  • Department of Pathology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06010, Türkiye.

ORCID-Profile: Gülsüm Karaahmetli, Sevgül Fakı, Feride Pınar Altay, Reyhan Ersoy

Zitieren

APA

Karaahmetli, G., Polat, Ş. B., Fakı, S., Akdoğan, L., Altay, F. P., Genç, B., Aksoy Altınboğa, A., Topaloğlu, O., Ersoy, R., & Çakır, B. (2026). Re-Analyzing Differentiated High-Grade Thyroid Carcinoma and Elevated Ki-67 Proliferation: A Single-Center Retrospective Study. Journal of Clinical Medicine, 15(11), 4173. https://doi.org/10.3390/jcm15114173

Vancouver

Karaahmetli G, Polat ŞB, Fakı S, Akdoğan L, Altay FP, Genç B, et al. Re-Analyzing Differentiated High-Grade Thyroid Carcinoma and Elevated Ki-67 Proliferation: A Single-Center Retrospective Study. Journal of Clinical Medicine. 2026;15(11):4173. doi:10.3390/jcm15114173

BibTeX
@article{Karaahmetli2026,
  author = {Karaahmetli, Gülsüm and Polat, Şefika Burçak and Fakı, Sevgül and Akdoğan, Leyla and Altay, Feride Pınar and Genç, Birgül and Aksoy Altınboğa, Ayşegül and Topaloğlu, Oya and Ersoy, Reyhan and Çakır, Bekir},
  title = {Re-Analyzing Differentiated High-Grade Thyroid Carcinoma and Elevated Ki-67 Proliferation: A Single-Center Retrospective Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {4173},
  doi = {10.3390/jcm15114173}
}
Kostenlos starten →